Bioxytran, Inc.
BIXT
$0.03
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.84M | -2.12M | -2.35M | -2.46M | -3.16M |
| Total Depreciation and Amortization | 11.70K | 11.50K | 11.50K | 8.80K | 7.80K |
| Total Amortization of Deferred Charges | -- | -- | 622.80K | 647.80K | 677.80K |
| Total Other Non-Cash Items | 1.15M | 790.10K | 346.40K | 438.20K | 770.00K |
| Change in Net Operating Assets | 1.08M | 794.90K | 955.00K | 918.50K | 1.27M |
| Cash from Operations | -597.80K | -526.50K | -417.40K | -449.40K | -439.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -32.30K | -23.10K | -29.00K | -38.10K | -22.20K |
| Cash from Investing | -32.30K | -23.10K | -29.00K | -38.10K | -22.20K |
| Total Debt Issued | 156.60K | 323.10K | 412.80K | 477.10K | 392.60K |
| Total Debt Repaid | -40.10K | -- | -- | -- | -- |
| Issuance of Common Stock | 584.70K | 439.00K | 13.40K | 0.00 | 63.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 387.50K | 292.20K | -- | -- | -- |
| Cash from Financing | 1.09M | 1.05M | 426.10K | 477.10K | 455.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 458.70K | 504.80K | -20.10K | -10.30K | -5.60K |